GT Biopharma, Inc. (GTBP) › Net IncomeGT Biopharma, Inc. (GTBP) — Net IncomeAnnual figures by fiscal year, from SEC filings.2010: -$3.00M2011: -$3.70M2012: -$5.17M2013: -$501.0K2014: -$23.49M2015: -$21.46M2016: $9.77M2017: -$144.17M2018: -$259.19M2019: -$38.65M2020: -$28.30M2021: -$58.01M2022: -$20.88M2023: -$7.60M2024: -$13.16M2025: -$28.35M-$28.35M2010Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$28.35M-115.4%2024-$13.16M-73.3%2023-$7.60M+63.6%2022-$20.88M+64.0%2021-$58.01M-105.0%2020-$28.30M+26.8%2019-$38.65M+85.1%2018-$259.19M-79.8%2017-$144.17M-1576.0%2016$9.77M+145.5%2015-$21.46M+8.6%2014-$23.49M-4588.4%2013-$501.0K+90.3%2012-$5.17M-39.8%2011-$3.70M-23.5%2010-$3.00M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share